|
|
| Research article summary (published 29 Jun 1993): |
A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
Full Abstract
OBJECTIVE: Recent studies assessing cardiovascular effects of desipramine (DMI) in pediatric patients consistently have found small, clinically benign, but statistically significant, increases in heart rate and electrocardiographic (ECG) conduction parameters. However, single, routine ECG recordings cannot fully assess potential infrequent rhythm disturbances. METHOD: We analyzed data from 24-hour ECG monitoring, two-dimensional Doppler echocardiography, and expert clinical cardiac examination of DMI-treated patients. Subjects were 71 children (N = 35) and adolescents (N = 36) receiving long-term treatment (means +/- SD = 1.5 +/- 1.2 years, median = 1.0 year) with DMI (means +/- SD = 3.5 +/- 1.6 mg/kg). RESULTS: Compared with previous observations in untreated healthy children. DMI-treated patients had significantly lower rates of sinus pauses and junctional rhythm, but significantly higher rates of single or paired premature atrial contractions and runs of supraventricular tachycardia. There was an association between DMI serum levels and paired premature atrial contractions, but no other associations were detected. CONCLUSIONS: These findings support the impression from previous ECG studies that DMI-associated cardiac effects in pediatric patients are quite benign. Nevertheless, it remains to be ascertained whether even minor cardiac abnormalities may predict later, evidently rare, adverse cardiovascular effects that may include sudden death.
Author information
Author/s: Biederman, J (J); Baldessarini, R J (RJ); Goldblatt, A (A); Lapey, K A (KA); Doyle, A (A); Hesslein, P S (PS);
Affiliation: Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
Grants: NIMH MH-31154 (Agency:NIMH NIH HHS) ; NIMH R01 MH-41314-01A2 (Agency:NIMH NIH HHS) ; NIMH-47370 (Agency:NIMH NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry (J Am Acad Child Adolesc Psychiatry), published in UNITED STATES. (Language: eng)
Reference: 1993-Jul; vol 32 (issue 4) : pp 805-13
Dates: Created 1993/08/27; Completed 1993/08/27; Revised 2007/11/15;
PMID: 8340302, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentIn: J Am Acad Child Adolesc Psychiatry. 1995 Feb;34(2):125-6. (PMID: 7534755)
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Effects of desipramine on autonomic control of the heart.
30 Jan 1994 - Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
29 Jun 1993 - ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine.
28 Feb 1996 - Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
27 Feb 1993 - Tricyclic medication in children and the QT interval: case report and discussion.
30 Jul 1995 - Side effects of methylphenidate and desipramine alone and in combination in children.
30 Aug 1993 - A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
29 Jun 2002 - Pharmacologic treatment of attention deficit hyperactivity disorder.
28 Feb 1992 - Commentary on unexplained death of children on Norpramin.
29 Jun 1991
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.